Quick Answer
LEMAITRE VASCULAR INC reported Stockholders Equity of $393.52 million for fiscal year 2025.
LEMAITRE VASCULAR INC Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $393.52M | +16.7% |
| 2024 | $337.29M | +13.2% |
| 2023 | $297.90M | +11.1% |
| 2022 | $268.20M | +5.5% |
| 2021 | $254.15M | +47.3% |
| 2020 | $172.57M | +16.5% |
| 2019 | $148.14M | +13.7% |
| 2018 | $130.24M | +18.6% |
| 2017 | $109.77M | +25.5% |
| 2016 | $87.50M | +12.3% |
| 2015 | $77.88M | +14.2% |
| 2014 | $68.21M | +20.6% |
| 2013 | $56.56M | +6.9% |
| 2012 | $52.89M | +1.5% |
| 2011 | $52.09M | -0.5% |
| 2010 | $52.36M | +8.6% |
| 2009 | $48.21M | +5.4% |
| 2008 | $45.75M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $378.92M | +14.5% | +4.5% |
| June 30, 2025 | $362.69M | +13.5% | +4.3% |
| March 31, 2025 | $347.57M | +12.7% | +3.0% |
| December 31, 2024 | $337.29M | +13.2% | +1.9% |
| September 30, 2024 | $331.07M | +14.7% | +3.6% |
| June 30, 2024 | $319.53M | +12.6% | +3.6% |
| March 31, 2024 | $308.50M | +12.5% | +3.6% |
| December 31, 2023 | $297.90M | +11.1% | +3.2% |
- LEMAITRE VASCULAR INC showed an increase of +16.7% in Stockholders Equity compared to the prior fiscal year.
- Over the 2008–2025 period, LEMAITRE VASCULAR INC’s stockholders equity has grown by 760.2% (from $45.75 million to $393.52 million).
- The most recent figure is from LEMAITRE VASCULAR INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: